
Charlotte Ariyan
David H. Koch Chair in Immunologic Studies · New York Presbyterian Hospital
Credentials: · · · ·
History
Research
Nivolumab plus ipilimumab in advanced melanoma
New England Journal of Medicine · 2013 · 3,387 citations
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Nature Genetics · 2019 · 3,156 citations
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Science · 2003 · 1,644 citations
- DC
30 papers

20 papers · 2 as a fellow
- DB
19 papers · 7 as a resident

17 papers
- KB
17 papers
- EB
14 papers · 8 as a resident
- AS
12 papers · 2 as a fellow

10 papers · 3 as a fellow
Grants
- 1977–2029
Summer Research Experiences for Medical Students Supervised by Faculty Mentors
National Cancer Institute · R25
Contact PI · $1.3M · Sloan-Kettering Inst Can Research
Clinical trials
- 2011–2017
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center




